FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A new device enhances liquid biopsy.

2.

Decrease seen in in situ breast cancer since 2009

3.

For elderly, unfit patients, the all-oral AML regimen shows promise.

4.

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

5.

Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot